Crystalline forms of ceftaroline fosamil
    3.
    发明授权
    Crystalline forms of ceftaroline fosamil 有权
    结晶形式的头孢洛林Fosamil

    公开(公告)号:US09534004B2

    公开(公告)日:2017-01-03

    申请号:US14653122

    申请日:2013-12-19

    Applicant: Sandoz AG

    CPC classification number: C07F9/6561 C07F9/65613

    Abstract: The present invention relates to novel crystalline forms of ceftaroline fosamil and to methods for their preparation. Furthermore the present invention relates to the use of the novel forms of ceftaroline fosamil for the preparation of an antibiotic medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel forms of ceftaroline fosamil and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel forms of ceftaroline fosamil and β-lactamase inhibitors.

    Abstract translation: 本发明涉及头孢洛林粉末的新型结晶形式及其制备方法。 此外,本发明涉及新型形式的头孢洛林粉剂用于制备抗生素药物的用途。 此外,本发明涉及包含有效量的头孢洛罗松受体的新形式的药物组合物及其制备方法。 最后,本发明涉及包含有效量的新型形式的头孢噻吩福沙米和β-内酰胺酶抑制剂的药物组合。

    NOVEL CRYSTALLINE FORMS OF CEFTAROLINE FOSAMIL
    4.
    发明申请
    NOVEL CRYSTALLINE FORMS OF CEFTAROLINE FOSAMIL 有权
    CEFTAROLINE FOSAMIL的新型结晶形式

    公开(公告)号:US20160200750A1

    公开(公告)日:2016-07-14

    申请号:US14653122

    申请日:2013-12-19

    Applicant: SANDOZ AG

    CPC classification number: C07F9/6561 C07F9/65613

    Abstract: The present invention relates to novel crystalline forms of ceftaroline fosamil and to methods for their preparation. Furthermore the present invention relates to the use of the novel forms of ceftaroline fosamil for the preparation of an antibiotic medicament. In addition the present invention relates to pharmaceutical compositions comprising an effective amount of the novel forms of ceftaroline fosamil and to methods of preparing the same. Finally the present invention relates to pharmaceutical combinations comprising an effective amount of the novel forms of ceftaroline fosamil and β-lactamase inhibitors.

    Abstract translation: 本发明涉及头孢洛林粉末的新型结晶形式及其制备方法。 此外,本发明涉及新型形式的头孢洛林粉剂用于制备抗生素药物的用途。 此外,本发明涉及包含有效量的头孢洛罗松受体的新形式的药物组合物及其制备方法。 最后,本发明涉及药物组合,其包含有效量的新型形式的头孢洛罗Fosamil和β-内酰胺酶抑制剂。

Patent Agency Ranking